Syneron Medical Earnings: Your Sneak Peek to the Big Announcement

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Syneron Medical (NASDAQ:ELOS) will report earnings before markets open on Wednesday, May 22nd. Syneron Medical Ltd. designs, develops, and markets aesthetic medical products based on proprietary Electro-Optical Synergy, or ELOS technologies. The Company’s products include Aurora – Hair Removal, Skin Treatment and Acne treatment systems.

Here is your Cheat Sheet to Syneron Medical Earnings:

Earnings Expectations: Analysts expect earnings of $0.02 per share on revenues of $61.19 million.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.17 to a profit $0.12. For the current year, the average estimate is a profit of $0.47, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Syneron Medical has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 114.98 54.73 189.53 228.32 263.62
Diluted EPS ($) 0.20 -0.86 -0.74 -1.44 -0.04

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 61.01 62.66 68.07 60.13 72.76
Diluted EPS ($) -0.2278 -0.07 -0.05 -0.06 0.1454

Past Performance:
Syneron Medical has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business